Access

Letter

Nature 456, 809-813 (11 December 2008) | doi:10.1038/nature07424; Received 11 March 2008; Accepted 10 September 2008; Published online 9 November 2008

Open Innovation Challenges

  • Methods to Analyze Consumer Emotions

    • Deadline: Jan 17 2010
    • Reward: $10,000 USD

    The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

naturejobs

A role for VEGF as a negative regulator of pericyte function and vessel maturation

Joshua I. Greenberg1, David J. Shields2, Samuel G. Barillas1, Lisette M. Acevedo2, Eric Murphy2, Jianhua Huang2, Lea Scheppke2, Christian Stockmann3, Randall S. Johnson3, Niren Angle1 & David A. Cheresh2

  1. Department of Surgery, School of Medicine,
  2. Department of Pathology and Moore's UCSD Cancer Center,
  3. Section of Molecular Biology, Division of Biology, University of California, San Diego, California 92093, USA

Correspondence to: David A. Cheresh2 Correspondence and requests for materials should be addressed to D.A.C. (Email: dcheresh@ucsd.edu).

Top

Angiogenesis does not only depend on endothelial cell invasion and proliferation: it also requires pericyte coverage of vascular sprouts for vessel stabilization1, 2. These processes are coordinated by vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) through their cognate receptors on endothelial cells and vascular smooth muscle cells (VSMCs), respectively3, 4. PDGF induces neovascularization by priming VSMCs/pericytes to release pro-angiogenic mediators5, 6, 7. Although VEGF directly stimulates endothelial cell proliferation and migration, its role in pericyte biology is less clear. Here we define a role for VEGF as an inhibitor of neovascularization on the basis of its capacity to disrupt VSMC function. Specifically, under conditions of PDGF-mediated angiogenesis, VEGF ablates pericyte coverage of nascent vascular sprouts, leading to vessel destabilization. At the molecular level, VEGF-mediated activation of VEGF-R2 suppresses PDGF-Rbeta signalling in VSMCs through the assembly of a previously undescribed receptor complex consisting of PDGF-Rbeta and VEGF-R2. Inhibition of VEGF-R2 not only prevents assembly of this receptor complex but also restores angiogenesis in tissues exposed to both VEGF and PDGF. Finally, genetic deletion of tumour cell VEGF disrupts PDGF-Rbeta/VEGF-R2 complex formation and increases tumour vessel maturation. These findings underscore the importance of VSMCs/pericytes in neovascularization8, 9 and reveal a dichotomous role for VEGF and VEGF-R2 signalling as both a promoter of endothelial cell function and a negative regulator of VSMCs and vessel maturation.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Eye vessels saved by rescuing their pericyte partners

Nature Medicine News and Views (01 Nov 2009)